Endoplasmic Reticulum Stress Is Involved in the Response of Human Laryngeal Carcinoma Cells to Carboplatin but Is Absent in Carboplatin-Resistant Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Brozovic, Anamaria ^a   Vuković, Lidija ^a   Polančac, Darija Stupin ^b   Arany, Istvan ^c   Köberle, Beate ^d   Fritz, Gerhard ^e   Fiket, Željka ^a   Majhen, Dragomira ^a   Ambriović Ristov, Andreja ^a   Osmak, Maja ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b Galapagos Research Center Ltd   (Croatia)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CCAAT ENHANCER BINDING PROTEIN; CELL MARKER; REACTIVE OXYGEN METABOLITE; SALUBRINAL; TEMPOL;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS LINKING; DOWN REGULATION; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LARYNX CARCINOMA; PROTEIN INDUCTION; RNA INTERFERENCE; TREATMENT RESPONSE;

APOPTOSIS; BLOTTING, SOUTHWESTERN; BLOTTING, WESTERN; CARBOPLATIN; CARCINOMA; CELL LINE, TUMOR; CELL SURVIVAL; CINNAMATES; CYCLIC N-OXIDES; DNA PRIMERS; DRUG RESISTANCE, NEOPLASM; ENDOPLASMIC RETICULUM STRESS; GENE SILENCING; HUMANS; LARYNGEAL NEOPLASMS; PLATINUM; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPIN LABELS; THIOUREA;

EID: 84884526075     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076397     Document Type: Article

References (51)

1. Bhutani M, Pathak AK, Mohan A, Guleria R, Kochupillai V, (2006) Small cell lung cancer: an update on therapeutic aspects. Indian J Chest Dis Allied Sci 48: 49-57.
2. Pectasides D, Pectasides E, Economopoulos T, (2007) Systemic therapy in metastatic or recurrent endometrial cancer. Cancer Treat Rev 33: 177-190.
3. Kubicek GJ, Kimler BF, Wang F, Reddy EK, Girod DA, et al. (2011) Chemotherapy in head and neck cancer: clinical predictors of tolerance and outcomes. Am J Clin Oncol 34: 380-384.
4. Siddik ZH, (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279.
5. Stewart DJ, (2007) Mechanisms of resistance to cisplatin and carboplatin. Crit Rev Oncol Hematol 63: 12-31.
6. Koberle B, Tomicic MT, Usanova S, Kaina B, (2010) Cisplatin resistance: preclinical findings and clinical implications. Biochim Biophys Acta 1806: 172-182.
7. Wang D, Lippard SJ, (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4: 307-320.
8. Blommaert FA, van Dijk-Knijnenburg HC, Dijt FJ, den Engelse L, Baan RA, et al. (1995) Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells. Biochemistry 34: 8474-8480.
9. Zwelling LA, Kohn KW, (1979) Mechanism of action of cis-dichlorodiammineplatinum(II). Cancer Treat Rep 63: 1439-1444.
10. Fichtinger-Schepman AM, van Dijk-Knijnenburg HC, van der Velde-Visser SD, Berends F, Baan RA, (1995) Cisplatin- and carboplatin-DNA adducts: is PT-AG the cytotoxic lesion? Carcinogenesis 16: 2447-2453.
11. Rabik CA, Dolan ME, (2007) Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 33: 9-23.
12. Todd RC, Lippard SJ, (2009) Inhibition of transcription by platinum antitumor compounds. Metallomics 1: 280-291.
13. Carozzi VA, Marmiroli P, Cavaletti G, (2010) The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity. Curr Cancer Drug Targets 10: 670-682.
14. Husain K, Whitworth C, Somani SM, Rybak LP, (2001) Carboplatin-induced oxidative stress in rat cochlea. Hear Res 159: 14-22.
15. Husain K, Whitworth C, Hazelrigg S, Rybak L, (2003) Carboplatin-induced oxidative injury in rat inferior colliculus. Int J Toxicol 22: 335-342.
16. Sue YM, Cheng CF, Chou Y, Chang CC, Lee PS, et al. (2011) Ectopic overexpression of haem oxygenase-1 protects kidneys from carboplatin-mediated apoptosis. Br J Pharmacol 162: 1716-1730.
17. Gorlach A, Klappa P, Kietzmann T, (2006) The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal 8: 1391-1418.
18. Schonthal AH, (2012) Targeting endoplasmic reticulum stress for cancer therapy. Front Biosci (Schol Ed) 4: 412-431.
19. Mandic A, Hansson J, Linder S, Shoshan MC, (2003) Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol Chem 278: 9100-9106.
20. Yu F, Megyesi J, Price PM, (2008) Cytoplasmic initiation of cisplatin cytotoxicity. Am J Physiol Renal Physiol 295: F44-52.
21. Liu H, Baliga R, (2005) Endoplasmic reticulum stress-associated caspase 12 mediates cisplatin-induced LLC-PK1 cell apoptosis. J Am Soc Nephrol 16: 1985-1992.
22. Osmak M, Bizjak L, Jernej B, Kapitanovic S, (1995) Characterization of carboplatin-resistant sublines derived from human larynx carcinoma cells. Mutat Res 347: 141-150.
23. Mickisch G, Fajta S, Keilhauer G, Schlick E, Tschada R, et al. (1990) Chemosensitivity testing of primary human renal cell carcinoma by a tetrazolium based microculture assay (MTT). Urol Res 18: 131-136.
24. Brozovic A, Fritz G, Christmann M, Zisowsky J, Jaehde U, et al. (2004) Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance. Int J Cancer 112: 974-985.
25. Herraiz C, Journe F, Abdel-Malek Z, Ghanem G, Jimenez-Cervantes C, et al. (2011) Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. Mol Endocrinol 25: 138-156.
26. Liedert B, Pluim D, Schellens J, Thomale J, (2006) Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei. Nucleic Acids Res 34: e47.
27. Kloft C, Appelius H, Siegert W, Schunack W, Jaehde U, (1999) Determination of platinum complexes in clinical samples by a rapid flameless atomic absorption spectrometry assay. Ther Drug Monit 21: 631-637.
28. Katano K, Kondo A, Safaei R, Holzer A, Samimi G, et al. (2002) Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res 62: 6559-6565.
29. Mahajan KN, Nick McElhinny SA, Mitchell BS, Ramsden DA, (2002) Association of DNA polymerase mu (pol mu) with Ku and ligase IV: role for pol mu in end-joining double-strand break repair. Mol Cell Biol 22: 5194-5202.
30. Reed E, (2010) DNA damage and repair in translational oncology: an overview. Clin Cancer Res 16: 4511-4516.
31. Safaei R, (2006) Role of copper transporters in the uptake and efflux of platinum containing drugs. Cancer Lett 234: 34-39.
32. Cheng CF, Juan SH, Chen JJ, Chao YC, Chen HH, et al. (2008) Pravastatin attenuates carboplatin-induced cardiotoxicity via inhibition of oxidative stress associated apoptosis. Apoptosis 13: 883-894.
33. Park GB, Kim YS, Lee HK, Song H, Cho DH, et al. (2010) Endoplasmic reticulum stress-mediated apoptosis of EBV-transformed B cells by cross-linking of CD70 is dependent upon generation of reactive oxygen species and activation of p38 MAPK and JNK pathway. J Immunol 185: 7274-7284.
34. Gregersen N, Bross P, (2010) Protein misfolding and cellular stress: an overview. Methods Mol Biol 648: 3-23.
35. Samali A, Fitzgerald U, Deegan S, Gupta S, (2010) Methods for monitoring endoplasmic reticulum stress and the unfolded protein response. Int J Cell Biol 2010: 830307.
36. Gallerne C, Prola A, Lemaire C, (2013) Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2. Biochim Biophys Acta 1833: 1356-1366.
37. Hiss DC, Gabriels GA, (2009) Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part I: targeting p53, Mdm2, GADD153/CHOP, GRP78/BiP and heat shock proteins. Expert Opin Drug Discov 4: 799-821.
38. Di Felice V, Lauricella M, Giuliano M, Emanuele S, Vento R, et al. (1998) The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells. Int J Oncol 13: 225-232.
39. Heffeter P, Jungwirth U, Jakupec M, Hartinger C, Galanski M, et al. (2008) Resistance against novel anticancer metal compounds: differences and similarities. Drug Resist Updat 11: 1-16.
40. Brozovic A, Damrot J, Tsaryk R, Helbig L, Nikolova T, et al. (2009) Cisplatin sensitivity is related to late DNA damage processing and checkpoint control rather than to the early DNA damage response. Mutat Res 670: 32-41.
41. Roos WP, Kaina B (2012) DNA damage-induced apoptosis: From specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett.
42. Hall MD, Okabe M, Shen DW, Liang XJ, Gottesman MM, (2008) The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol Toxicol 48: 495-535.
43. Holzer AK, Manorek GH, Howell SB, (2006) Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin. Mol Pharmacol 70: 1390-1394.
44. Samimi G, Safaei R, Katano K, Holzer AK, Rochdi M, et al. (2004) Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin Cancer Res 10: 4661-4669.
45. Materna V, Liedert B, Thomale J, Lage H, (2005) Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells. Int J Cancer 115: 393-402.
46. Katano K, Safaei R, Samimi G, Holzer A, Rochdi M, et al. (2003) The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. Mol Pharmacol 64: 466-473.
47. Brozovic A, Ambriovic-Ristov A, Osmak M, (2010) The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin. Crit Rev Toxicol 40: 347-359.
48. Brozovic A, Majhen D, Roje V, Mikac N, Jakopec S, et al. (2008) alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species. Mol Pharmacol 74: 298-306.
49. Moon IJ, Kim KR, Chu HS, Kim SH, Chung WH, et al. (2011) N-acetylcysteine and N-nitroarginine methyl ester attenuate Carboplatin-induced ototoxicity in dissociated spiral ganglion neuron cultures. Clin Exp Otorhinolaryngol 4: 11-17.
50. England K, Driscoll CO, Cotter TG, (2006) ROS and protein oxidation in early stages of cytotoxic drug induced apoptosis. Free Radic Res 40: 1124-1137.
51. Boyce M, Bryant KF, Jousse C, Long K, Harding HP, et al. (2005) A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 307: 935-939.